MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from the sale of
equity, net of issuance...
$14,662,268
Net cash provided by
(used in) financing...
$14,662,268
Effect of exchange rate
on changes on cash,...
$295,406
Net increase
(decrease) in cash, cash...
$8,521,859
Canceled cashflow
$6,435,815
Net loss
$1,864,092
Effect of foreign
currency remeasurement
-$224,289
Prepaid insurance
expense
-$195,365
Depreciation and
amortization expense
$165,789
Share-based compensation
$93,701
Non-cash rent expense
-$87,269
Net cash used in
operating activities
-$6,435,815
Canceled cashflow
$2,630,505
Change in fair value of
accompanying warrant...
-$5,379,434
Accrued expenses and
other current...
-$1,602,739
Accounts receivable,
non-trade
$1,108,150
Accounts payable
-$850,019
Operating lease
liabilities
-$85,210
Deferred tax liability
-$34,793
Change in fair value of
contingent consideration
-$5,975
Back
Back
Cash Flow
source: myfinsight.com
Neuphoria Therapeutics Inc. (NEUP)
Neuphoria Therapeutics Inc. (NEUP)